Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Gene Techno Science Co Ltd (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013297
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, for oncology; and GND-007 for immunological disease. GTS also develops biosimilar products, which include GBS-008 for infectious disease; GBS-010 for oncology; and GBS-011 for renal disease. GTS’ primary product granulocyte colony stimulating factor (G-CSF) promotes the differentiation and growth of neutrophils, one of the white blood cells, and increases neutrophils’ function. It conducts research and development of new biopharmaceuticals collaborating with universities and research institutions. The company has operations in Osaka, Sapporo, and Tokyo. GTS is headquartered in Sapporo, Japan.

Gene Techno Science Co Ltd (4584) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gene Techno Science, AIN Holdings, North Pacific Bank Form Joint Venture 10
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 14
Gene Techno Science Enters into Co-Development Agreement with Sanwa Kagaku Kenkyusho 15
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 16
Gene Techno Science Enters Into Co-Development Agreement With Fuso Pharma Industries 17
Equity Offering 18
Gene Techno Science Raises USD2.7 Million in Private Placement of Shares 18
Gene Techno Science Raises USD4.3 Million in Private Placement of Shares 19
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 20
Gene Techno Science Completes IPO Of Shares 21
Debt Offering 22
Gene Techno Science Completes Private Placement Of Bonds Due 2018 For US$2 Million 22
Gene Techno Science Co Ltd – Key Competitors 23
Gene Techno Science Co Ltd – Key Employees 24
Gene Techno Science Co Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Gene Techno Science Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Gene Techno Science Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Gene Techno Science, AIN Holdings, North Pacific Bank Form Joint Venture 10
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 11
Gene Techno Science Enters into Research Agreement with Juntendo University 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Gene Techno Science Enters into Co-Development Agreement with Senju Pharma 14
Gene Techno Science Enters into Co-Development Agreement with Sanwa Kagaku Kenkyusho 15
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 16
Gene Techno Science Enters Into Co-Development Agreement With Fuso Pharma Industries 17
Gene Techno Science Raises USD2.7 Million in Private Placement of Shares 18
Gene Techno Science Raises USD4.3 Million in Private Placement of Shares 19
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 20
Gene Techno Science Completes IPO Of Shares 21
Gene Techno Science Completes Private Placement Of Bonds Due 2018 For US$2 Million 22
Gene Techno Science Co Ltd, Key Competitors 23
Gene Techno Science Co Ltd, Key Employees 24
Gene Techno Science Co Ltd, Other Locations 25

★海外企業調査レポート[Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Findel plc:企業の戦略・SWOT・財務分析
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Otsuka Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Ultimovacs AS-製薬・医療分野:企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • Federal Electricity & Water Authority:企業の戦略的SWOT分析
    Federal Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Keyence Corp (6861):企業の財務・戦略的SWOT分析
    Keyence Corp (6861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Woodward Inc:戦略・SWOT・企業財務分析
    Woodward Inc - Strategy, SWOT and Corporate Finance Report Summary Woodward Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • VentriPoint Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company provides ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. I …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務分析
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • China State Shipbuilding Corp:企業の戦略・SWOT・財務分析
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sberbank of Russia:企業の戦略・SWOT・財務情報
    Sberbank of Russia - Strategy, SWOT and Corporate Finance Report Summary Sberbank of Russia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Servest Group Ltd:企業の戦略的SWOT分析
    Servest Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cooper Energy Ltd (COE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, O …
  • Delphi Genetics SA-製薬・医療分野:企業M&A・提携分析
    Summary Delphi Genetics SA (Delphi Genetics) is a genetic engineering and bioproductions company that develops products and technologies for gene cloning and protein expression in bacteria. The company offers services which include gene synthesis, DNA cloning and mutagenesis Plasmid production, prot …
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Novita Healthcare Ltd (NHL):企業の財務・戦略的SWOT分析
    Novita Healthcare Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aevi Genomic Medicine Inc (GNMX):医療機器:M&Aディール及び事業提携情報
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Hellenic Petroleum SA (ELPE):企業の財務・戦略的SWOT分析
    Hellenic Petroleum SA (ELPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆